» Articles » PMID: 11279151

Substrate Hydrolysis by Matrix Metalloproteinase-9

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2001 Mar 30
PMID 11279151
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

The catalytic clefts of all matrix metalloproteinases (MMPs) have a similar architecture, raising questions about the redundancy in substrate recognition across the protein family. In the present study, an unbiased phage display strategy was applied to define the substrate recognition profile of MMP-9. Three groups of substrates were identified, each occupying a distinct set of subsites within the catalytic pocket. The most prevalent motif contains the sequence Pro-X-X-Hy-(Ser/Thr) at P(3) through P(2'). This sequence is similar to the MMP cleavage sites within the collagens and is homologous to substrates the have been selected for other MMPs. Despite this similarity, most of the substrates identified here are selective for MMP-9 over MMP-7 and MMP-13. This observation indicates that substrate selectivity is conferred by key subsite interactions at positions other than P(3) and P(1'). This study shows that MMP-9 has a unique preference for Arg at both P(2) and P(1), and a preference for Ser/Thr at P(2'). Substrates containing the consensus MMP-9 recognition motif were used to query the protein data bases. A surprisingly limited list of putative physiologic substrates was identified. The functional implications of these proteins lead to testable hypotheses regarding physiologic substrates for MMP-9.

Citing Articles

Substrate O-glycosylation actively regulates extracellular proteolysis.

Madzharova E, Sabino F, Kalogeropoulos K, Francavilla C, Auf dem Keller U Protein Sci. 2024; 33(8):e5128.

PMID: 39074261 PMC: 11285871. DOI: 10.1002/pro.5128.


Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron.

Benlarbi M, Laroche G, Fink C, Fu K, Mulloy R, Phan A iScience. 2022; 25(11):105316.

PMID: 36254158 PMC: 9549715. DOI: 10.1016/j.isci.2022.105316.


A Protease Activatable Interleukin-2 Fusion Protein Engenders Antitumor Immune Responses by Interferon Gamma-Dependent and Interferon Gamma-Independent Mechanisms.

Norville K, Skrombolas D, Ferry S, Kearns N, Frelinger J J Interferon Cytokine Res. 2022; 42(7):316-328.

PMID: 35834651 PMC: 9347422. DOI: 10.1089/jir.2022.0043.


MMP9: A Tough Target for Targeted Therapy for Cancer.

Augoff K, Hryniewicz-Jankowska A, Tabola R, Stach K Cancers (Basel). 2022; 14(7).

PMID: 35406619 PMC: 8998077. DOI: 10.3390/cancers14071847.


Identification of a Common Pharmacophore for Binding to MMP2 and RGD Integrin: Towards a Multitarget Approach to Inhibit Cancer Angiogenesis and Metastasis.

Baldini L, Lenci E, Bianchini F, Trabocchi A Molecules. 2022; 27(4).

PMID: 35209039 PMC: 8879803. DOI: 10.3390/molecules27041249.